Knight Therapeutics Inc.

10:58 AM EST - Knight Therapeutics Inc. : Reported financial results for its first quarter ended March 31, 2020. Revenues were $45,839, an increase of $42,883 or 1,451% over prior year. Interest income generated of $4,649 a decrease of $1,241 or 21% over prior year. Net loss for the period was $9,477 compared to net income for the period of $5,189 in prior year. Adjusted earnings of $6,435, an increase of $1,806 or 39% over prior year. Knight Therapeutics Inc. shares T.GUD are trading down $0.45 at $6.82.